National Cancer Institute  www.cancer.gov  U.S. National Institutes of Health
 


Cancer Trends Progress Report – 2009/2010 Update

Skip to content
Progress Report  Home

Progress Report Tools
 Print this page
 Generate custom report



In the Report
Introduction
Trends-at-a-Glance
Summary Tables
Prevention
Early Detection
Diagnosis
Treatment
Bladder Cancer Treatment
Breast Cancer Treatment
Colorectal Cancer Treatment
Kidney Cancer Treatment
> Lung Cancer Treatment
Ovarian Cancer Treatment
Prostate Cancer Treatment
Life After Cancer
End of Life



Lung Cancer Treatment
Treatment

Between 1996 and 2005 there was a substantial increase in the use of chemotherapy for patients with non-small cell lung cancer stages IIIB or IV. Older patients were less likely to receive chemotherapy than younger patients.

On this page:

Benefits of Treatment

Improved survival and palliation of disease related symptoms have been reported with the use of chemotherapy and radiation.

Back to Top

Measure

Chemotherapy following the diagnosis of stage IIIB or IV non-small cell lung cancer.

Back to Top

Period – 1996 and 2005

Back to Top

Trends – Rising in patients ages 20–49, 60–69, and 70–79.

Back to Top

Most Recent Estimates

Percent of patients diagnosed with stage IIIB or IV non-small cell lung cancer receiving chemotherapy in 2005:

  • Age 20–49, 77 percent
  • Age 50–59, 61 percent
  • Age 60–69, 60 percent
  • Age 70–79, 47 percent
  • Age 80 or older, 29 percent

Back to Top

Healthy People 2010 Targets

There are no Healthy People 2010 targets for the treatment of lung cancer.

Back to Top

Groups at High Risk for Not Receiving Appropriate Treatment

Overall, the use of chemotherapy decreases as the age of the patient increases. Less than 50 percent of patients age 70 or older receive chemotherapy.

Back to Top

Key Issues

There have been significant increases in the use of chemotherapy for the treatment of advanced lung cancer in most age groups. Although patients age 50–59 did not have a significant increase in their use of chemotherapy in 2005, these patients had a much higher use of chemotherapy than other age groups in 1996. While there have been no significant increases in patients age 80 or older, co-morbid conditions and performance status may influence their treatment decisions.

Back to Top

Additional Information on Lung Cancer Treatment

Back to Top

Back: Kidney Cancer Treatment

National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthUSA.gov